- Home
- LDTC vs GBIO Comparison
LDTC vs GBIO Comparison
Compare LDTC & GBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LDTC
- GBIO
- Stock Information
- Founded
- LDTC 2007
- GBIO 2016
- Country
- LDTC Canada
- GBIO United States
- Employees
- LDTC N/A
- GBIO N/A
- Industry
- LDTC Blank Checks
- GBIO Biotechnology: Pharmaceutical Preparations
- Sector
- LDTC Finance
- GBIO Health Care
- Exchange
- LDTC Nasdaq
- GBIO Nasdaq
- Market Cap
- LDTC 37.5M
- GBIO 35.2M
- IPO Year
- LDTC N/A
- GBIO 2020
- Fundamental
- Price
- LDTC $0.43
- GBIO $0.37
- Analyst Decision
- LDTC Buy
- GBIO Strong Buy
- Analyst Count
- LDTC 2
- GBIO 4
- Target Price
- LDTC $3.00
- GBIO $7.33
- AVG Volume (30 Days)
- LDTC 104.2K
- GBIO 475.8K
- Earning Date
- LDTC 05-13-2025
- GBIO 03-13-2025
- Dividend Yield
- LDTC N/A
- GBIO N/A
- EPS Growth
- LDTC N/A
- GBIO N/A
- EPS
- LDTC N/A
- GBIO N/A
- Revenue
- LDTC $331,997.00
- GBIO $19,892,000.00
- Revenue This Year
- LDTC $1,128.94
- GBIO N/A
- Revenue Next Year
- LDTC $169.93
- GBIO $10.90
- P/E Ratio
- LDTC N/A
- GBIO N/A
- Revenue Growth
- LDTC 141.86
- GBIO 236.92
- 52 Week Low
- LDTC $0.22
- GBIO $0.36
- 52 Week High
- LDTC $2.75
- GBIO $4.52
- Technical
- Relative Strength Index (RSI)
- LDTC 33.16
- GBIO 31.11
- Support Level
- LDTC $0.41
- GBIO $0.36
- Resistance Level
- LDTC $0.64
- GBIO $0.50
- Average True Range (ATR)
- LDTC 0.05
- GBIO 0.05
- MACD
- LDTC -0.00
- GBIO -0.00
- Stochastic Oscillator
- LDTC 6.04
- GBIO 17.66
About LDTC LeddarTech Holdings Inc.
LeddarTech Holdings Inc is a company that develops and provides comprehensive perception software solutions that enable the deployment of ADAS and autonomous driving (AD) applications. Its automotive-grade software applies AI and computer vision algorithms to generate accurate 3D models of the environment, allowing for decision-making and safer navigation. The company generates the majority of its revenue from France, Canada, and the United states.
About GBIO Generation Bio Co.
Generation Bio Co is a genetics medicine company that is focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable highly differentiated therapeutic applications. Its first platform is a potent, highly selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for highly selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.